Oncosil Medical Ltd
ASX:OSL

Watchlist Manager
Oncosil Medical Ltd Logo
Oncosil Medical Ltd
ASX:OSL
Watchlist
Price: 0.005 AUD Market Closed
Updated: May 17, 2024

Oncosil Medical Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Oncosil Medical Ltd
Income from Continuing Operations Peer Comparison

Comparables:
ADO
PIQ
CTE
GSS
E
EZZ

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Oncosil Medical Ltd
ASX:OSL
Income from Continuing Operations
-AU$11.7m
CAGR 3-Years
-28%
CAGR 5-Years
-5%
CAGR 10-Years
-16%
Anteotech Ltd
ASX:ADO
Income from Continuing Operations
-AU$11.5m
CAGR 3-Years
-49%
CAGR 5-Years
-39%
CAGR 10-Years
-19%
Proteomics International Laboratories Ltd
ASX:PIQ
Income from Continuing Operations
-AU$6m
CAGR 3-Years
-36%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Cryosite Ltd
ASX:CTE
Income from Continuing Operations
AU$1.6m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
4%
Genetic Signatures Ltd
ASX:GSS
Income from Continuing Operations
-AU$18m
CAGR 3-Years
N/A
CAGR 5-Years
-40%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Income from Continuing Operations
AU$3.6m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Oncosil Medical Ltd's Income from Continuing Operations?
Income from Continuing Operations
-11.7m AUD

Based on the financial report for Dec 31, 2023, Oncosil Medical Ltd's Income from Continuing Operations amounts to -11.7m AUD.

What is Oncosil Medical Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-16%

Over the last year, the Income from Continuing Operations growth was -10%. The average annual Income from Continuing Operations growth rates for Oncosil Medical Ltd have been -28% over the past three years , -5% over the past five years , and -16% over the past ten years .